On Wednesday afternoon, General Dynamics announced that its board of directors had declared its next quarterly dividend would be $1.50 per share. That's nearly 6% higher than the previous ...

General Dynamics increased its dividend to $1.50 from $1.42. The new payout, equal to $6 a year, represents an annual yield of about 2.4% based on Tuesday's closing price of $250.80. The Reston ...

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

BTIG downgraded General Dynamics (GD) to Neutral from Buy with no price target 2025 is “shaping up to be another lackluster year” as continued regulatory and supply chain headwinds could ...

These investor-pleasing moves are almost always met with approval, and that dynamic was in play Wednesday for veteran aerospace and defense company General Dynamics (NYSE: GD). The company's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

General Dynamics Corporation's ( NYSE:GD ) periodic dividend will be increasing on the 9th of May to $1.50, with... General Dynamics (GD) concluded the recent trading session at $264.55 ...

In this article, we are going to take a look at where General Dynamics Corporation (NYSE:GD) stands against other best large cap defense stocks to buy now. The world has been rocked with conflict ...

In this article, we are going to take a look at where General Dynamics Corporation (NYSE:GD) stands against the other defense stocks. The world has been rocked by conflict over the last three ...

Reston, Virginia-based General Dynamics Corporation (GD) is an aerospace and defense company that specializes in high-end design, engineering, and manufacturing to deliver state-of-the-art ...

according to previous comments by Aardvark. The biotech has evaluated ARD-101 in a trio of phase 2 studies, including a trial in 20 patients with general obesity that showed individuals who ...

Cyrus Renault is an important villain on the ABC soap opera General Hospital, first played by Jeff Kober when he joined the show in 2020. Kober's performance made Cyrus a key part of the drama ...